Labor Market Pulse · Life Sciences · September 2026
Life Sciences Labor Market Report: MS NONMETROPOLITAN AREA — September 2026
Nonmetro Mississippi pays regulatory and clinical talent above national rates.
Regulatory Affairs Specialists command $111,675 locally versus a flat $104,000 nationally, while CRA pay runs $99,605 against $90,956 — a scarcity premium showing up even as generic pharma manufacturing employment keeps shrinking statewide.
Free archive edition. Published by WageScape as sent to subscribers; data as of September 2026.
Key indicators
- County unemployment spread: 11.7% vs 3.1% — Jefferson County vs Jones County, Aug 2026
- Statewide job openings rate: 5.4% — vs 4.5% national rate, Oct 2025
- Regulatory Affairs advertised pay: $111,675 — vs $104,000 national, flat YoY
- MS employment growth forecast: -0.1%/yr — Projected annually, 2026-2030
Key takeaways
Regulatory Affairs pay in this metro is outrunning the national rate.
Advertised Regulatory Affairs Specialist pay sits at $111,675 locally against a flat $104,000 nationally, a reversal of the usual nonmetro discount. Local scarcity for regulatory talent capable of navigating faster FDA pathways appears to be forcing premiums even in a thin labor market.
Clinical Research Associate pay premium signals a thin specialist bench.
Metro CRA pay at $99,605 runs roughly 9% above the $90,956 national median, an unusual inversion for a nonmetro geography. This likely reflects a small qualified pool stretched across Mississippi's limited clinical trial infrastructure, raising retention stakes for any employer running active studies here.
Lab Technician pay erosion tracks broader manufacturing softness.
Advertised pay for Lab Technicians fell moderately both locally ($40,492) and nationally ($47,402), consistent with declining generic pharma manufacturing employment in the state. Entry-level technical roles may be absorbing the weakest demand signal in an otherwise tightening specialist market.
Outsourcing math favors CDMOs over local GMP expansion.
Mississippi's generic pharmaceutical manufacturing workforce has shrunk on an annualized basis through 2026 while statewide employment is projected to decline 0.1% annually through 2030. Build-vs-outsource decisions in this metro increasingly favor CDMO capacity in stronger labor markets over internal manufacturing investment.
Median advertised pay by role — MS NONMETROPOLITAN AREA
| Role | 25th percentile | Median advertised pay | 75th percentile | Metro trend | National median |
|---|---|---|---|---|---|
| Research Scientist * | $109,700 | $115,594 | $117,067 | Significant increase | $131,354 |
| Clinical Research Associate | $57,993 | $99,605 | $106,220 | Significant increase | $90,956 |
| Lab Technician * | $39,520 | $40,492 | $46,279 | Moderate decline | $47,402 |
| Regulatory Affairs Specialist * | $78,759 | $111,675 | $111,675 | Significant increase | $104,000 |
| Clinical Data Manager | — | — | — | No data | $123,031 |
| Biostatistician * | $98,529 | $135,548 | $144,199 | No data | $133,322 |
| Validation Engineer * | $105,020 | $105,020 | $105,020 | Significant increase | $108,377 |
* State-level figure shown where metro postings were too few.
WageScape's median is calibrated to correct for spurious low-value postings (reported as the 60th percentile of raw advertised pay). Download: CSV · JSON
Local market conditions
Nonmetro Mississippi's labor pool remains structurally uneven — Jefferson County unemployment sits at 11.7% and Issaquena at 9.9%, while Lafayette and Jones counties hold near 3.1-3.2%, reflecting a fragmented rural economy rather than a single coherent labor market. Statewide job openings ran at 5.4% as of October 2025, above the 4.5% national rate, even as Mississippi's generic pharmaceutical manufacturing employment has continued an annualized decline through 2026.
What it means
Wide county-level unemployment dispersion means nonmetro Mississippi offers no uniform labor supply story — recruitment strategy should treat high-unemployment counties (Jefferson, Issaquena, Holmes) and tighter labor counties (Jones, Lafayette) as distinct talent markets with different sourcing timelines. Declining generic pharma manufacturing headcount locally, paired with above-average statewide job-opening friction, strengthens the case for CDMO partnerships over new GMP buildout in this geography. Consider evaluating site-location and outsourcing decisions against county-level labor availability data rather than statewide averages alone.
Looking ahead
Worth watching: County-level unemployment divergence (11.7% Jefferson vs 3.1% Jones) may widen further as manufacturing WARN activity continues statewide. Track whether displaced manufacturing workers migrate toward higher-unemployment counties seeking life sciences openings.
Emerging pressure point: National biopharma layoffs (BioMarin, Bristol Myers) are concentrated in consolidation functions, not execution-critical roles like CMC and regulatory. Watch whether any released specialist talent becomes available to Mississippi-based employers via remote or relocation-friendly postings.
Potential inflection point: Hitachi Energy's state investment announcement signals continued manufacturing-sector interest in Mississippi despite life sciences manufacturing softness. Monitor whether this draws skilled technical labor away from pharma/biotech competitors in adjacent counties.
Early indicator: Statewide job openings rate (5.4%) continues to exceed the national rate, suggesting hiring friction may persist into Q4. Recruitment timelines for regulatory and clinical roles should be budgeted with this above-average friction in mind.
Methodology
Advertised pay from active employer job postings, not survey data. WageScape's median is calibrated to correct for spurious low-value postings: distribution analysis shows roughly the lowest 10% of raw values are erroneous entries, so the reported median is the 60th percentile of raw advertised pay. WageScape observes 98% of U.S. job openings daily.
Free to read and cite with attribution to WageScape. Terms of use.